Success of smoking cessation in patients with chronic obstructive pulmonary disease;Kronik obstrüktif akciǧer hastaliǧi olgularinda sigarayi birakma başarisi

Tuberkuloz ve Toraks

Volumn 54, Issue 1, 2006, Pages 43-50

  Aytemur Solak, Zeynep ^a   Kaçmaz Başoǧlu, Özen ^a   Erdinç, Ertürk ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

COPD; FEV1; Smoking cessation

Indexed keywords

AMFEBUTAMONE;

ARTICLE; BEHAVIOR THERAPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CONTROLLED STUDY; FORCED EXPIRATORY VOLUME; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; NICOTINE REPLACEMENT THERAPY; SMOKING CESSATION; TREATMENT OUTCOME;

BUPROPION; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NICOTINE; OUTCOME ASSESSMENT (HEALTH CARE); PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING CESSATION; TURKEY;

EID: 33745485612     PISSN: 04941373     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Wouters EF. Management of severs COPD. Lancet 2004; 364: 883-95.
2. Tashkin DP, Kanner R, Bailey W, et al. Smoking cessation in patients with chronic obstructive pulmonary disease: A double-blind, placebo-controlled, randomised trial. Lancet 2001; 357: 1571-5.
3. Sullivan SD, Ramsey SD, Lee TA. The economic burden of COPD. Chest 2000; 117 (Suppl 2): 5-9.
4. US Department of Health and Human Services. The health benefits of smoking cessation. Rockville, MD: Office on Smoking and Health. Department of Health and Human Services 1990; Publication Ho. (CDC) 8.416
5. 1. Eur Respir J 1989; 2: 811-6.
6. Wagena EJ, van der Meer RM, Ostelo RJ, et al. The efficacy of smoking cessation strategies in people with chronic obstructive pulmonary disease: Results from a systematic review. Respir Med 2004; 98: 805-15.
7. Willemse BW, Postma DS, Timens W, ten Hacken HH. The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation. Eur Respir J 2004; 23: 464-76.
8. Pauwels RA. National and international guidelines for COPD: The need for evidence. Chest 2000; 117: 20-2.
9. Sherman SE, Lanto AB, Hield M, Yano E. Smoking cessation care received by veterans with chronic obstructive pulmonary disease. J Rehabil Res Dev 2003; 40 (5 Suppl 2): 1-12.
10. Jimenez-Ruiz CA, Masa F, Miravitlles M, et al. IBERPOC Study Investigators. Smoking characteristics. Differences in attitudes and dependence between healty smokers ans smokers with COPD. Chest 2001; 119: 1365-70.
11. Sachs D. Treatment of cigarette dependency: What American pulmonary physicians do? Am Rev Respir Dis 1984; 129: 1010-3.
12. Pauwels RA, Buist AS, Caluerly PM, et al. The GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. HHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary. Am J Respir Crit Care Med 2001; 163: 1256-76.
13. Fabbri LM, Hurd SS. GOLD Scientific Committee. Global Strategy for the Diagnosis, Management and Prevention of COPD: 2003 update. Eur Respir J 2003; 22: 1-2.
14. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361-70.
15. Fagerstrom KO, Heatherton TF, Kozlowski LT. Micotine addiction and its assessment. Ear Nosa Throat J 1992; 69: 763-7.
16. A clinical practice guideline for treating tobacco use and dependence. A US Public Health Service Report. JAMA 2000; 283: 3244-54.
17. Jorenby DE, Smith SS, Flore MC, et al. Varying nicotine patch dose and type of smoking cessation counselling. JAMA 1995;274:1347-52.
18. Özge C, Tümkaya M, Özgür ES, Eker S. Sotunumsal yakinmasi olan hastalarin sigara alişkanlik durumlarinin deǧerlendirilmesi. Solunum Hastaliklari 2005; 16: 12-7.
19. Sampablo I, Lores L, Coll-Klein F, et al. Predictive factors in smoking cessation with bupropion and nicotine patches. Monaldi Arch Chest Disease 2003; 59: 171-6.
20. Monninkhof E, van der Valk P, van der Palen J, et at. The effect of a minimal contact smoking cessation programme in out-patients with chronic obstructive pulmonary disease: A pre-post-test study. Patient Educ Couns 2004; 55: 121-8.
21. Uzaslan EK, Ǒzyardimci N, Karadaǧ M, et al The physician's intervention in smoking cessation: Results of the five years of smoking cessation clinic. Ann Med Sci 2000; 9: 63-9.
22. Solak ZA, Telli CG, Erdinç E. Sigarayi birakma tedavisinin sonuçlari. Toraks Dergisi 2003; 4: 73-7.
23. Can C, Öztuna F, Özlü T. The evaluation of outpatient smoking cessation clinic results. Tuberk Toraks 2004; 52: 63-74.
24. Schwarte J, Wiss ST. Dietary factors and their relation to respiratory symptoms. Am J Epidemiol 1990; 132: 67-76.
25. Menezes AMB, Victora CG, Rigatto M. Prevalence and risk factors for chronic bronchitis in Pelotas, RS, Brazil: A population-based study. Thorax 1994; 49: 1217-21.
26. Pierce JP, Fiore MC, Mouotny TE, et al. Trends in cigarette smoking in the United States: Projections to the year 2000. JAMA 1989; 261: 61-5.
27. Peat JK, Woolcock AJ, Cullen K. Decline of lung function and development of chronic airflow limitation: A longitudinal study of non-smokers and smokers in Busselton, Western Australia. Thorax 1990; 45: 32-7.
28. Scanlon PD, Connett JE, Waller A, et al. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med 2001; 161: 381-90.